Suffredini A F, Fantuzzi G, Badolato R, Oppenheim J J, O'Grady N P
Critical Care Medicine Department, Warren G. Magnuson Clinical Center, Bethesda, Maryland 20892-1662, USA.
J Clin Immunol. 1999 Jul;19(4):203-14. doi: 10.1023/a:1020563913045.
Innate or natural immunity is a highly conserved defense mechanism against infection found in all multicellular organisms. The acute phase response is the set of immediate inflammatory responses initiated by pattern recognition molecules. These germ cell-encoded proteins recognize microbial pathogens based on shared molecular structures and induce host responses that localize the spread of infection and enhance systemic resistance to infection. Innate immunity also influences the initiation and type of adaptive immune response by regulating T cell costimulatory activity and antigen presentation by antigen presenting cells and by influencing mediator production, which affects lymphocyte function and trafficking. Acute phase protein concentrations rapidly increase after infection, and their production is controlled primarily by IL-6- and IL-1-type cytokines. The acute phase proteins provide enhanced protection against microorganisms and modify inflammatory responses by effects on cell trafficking and mediator release. For example, serum amyloid A has potent leukocyte activating functions including induction of chemotaxis, enhancement of leukocyte adhesion to endothelial cells, and increased phagocytosis. The constellation of inflammatory responses seen after endotoxin administration to humans represents an in vivo model of the acute phase response. Studies with inflammatory modifying agents, such as soluble dimeric TNF receptor and IL-10, show that these responses are not dependent on a single mediator but result from multiple overlapping inflammatory pathways. Understanding the factors that initiate and alter the magnitude and duration of the acute phase response represents an important step in the development of new therapies for infectious and inflammatory diseases.
固有免疫或天然免疫是一种在所有多细胞生物中都存在的、高度保守的抗感染防御机制。急性期反应是由模式识别分子引发的一系列即时性炎症反应。这些由生殖细胞编码的蛋白质基于共同的分子结构识别微生物病原体,并诱导宿主产生反应,从而限制感染的扩散并增强全身抗感染能力。固有免疫还通过调节T细胞共刺激活性、抗原呈递细胞的抗原呈递以及影响介质产生来影响适应性免疫反应的启动和类型,而介质产生会影响淋巴细胞的功能和运输。感染后急性期蛋白浓度迅速升高,其产生主要受IL-6和IL-1型细胞因子控制。急性期蛋白可增强对微生物的保护,并通过影响细胞运输和介质释放来调节炎症反应。例如,血清淀粉样蛋白A具有强大的白细胞激活功能,包括诱导趋化作用、增强白细胞与内皮细胞的黏附以及增加吞噬作用。给人类注射内毒素后出现的一系列炎症反应代表了急性期反应的体内模型。使用炎症调节剂(如可溶性二聚体TNF受体和IL-10)进行的研究表明,这些反应并非依赖于单一介质,而是由多条重叠的炎症途径导致的。了解引发和改变急性期反应的幅度和持续时间的因素是开发针对感染性和炎症性疾病新疗法的重要一步。